Skip to main content
. Author manuscript; available in PMC: 2023 Feb 3.
Published in final edited form as: J Am Coll Cardiol. 2022 Aug 16;80(7):697–718. doi: 10.1016/j.jacc.2022.05.038

Figure 2. Selected Clinical Variables Across the Spectrum of Pulmonary Vascular Disease.

Figure 2

Spider plots of selected clinical variables across the spectrum of pulmonary vascular disease including disease comparators. Presented are characteristics of cardiac physiology: (A) N-terminal-pro-brain natriuretic peptide (NT-proBNP), (B) 6-minute walk distance (6MWD), (C) sleep study (% recording time <90% saturation), (D) ground glass on chest computed tomography (CT), (E) diffusing capacity for carbon monoxide (DLCO), and (F) echocardiographic (ECHO) right atrial (RA) volume index. *Significant difference across PH or comparator groups. Median values shown. Comparator group 5 not included in statistical comparisons. †Significant difference at level 0.05 between comparators and PH participants within group. G = group.